Skip to content

6-KAccepted Sep 25, 4:30 PM ET

NERVGEN PHARMA CORP. 6-K

NGENNERVGEN PHARMA CORP.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:30 PM

Sep 25, 2026

Filed

Sep 25, 2026

Documents

1

Size

15.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.